2. News & RNS
3. Finance News
4. UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

Fri, 30th Jan 2015 06:16

UK Earnings, Trading Statements Calendar
Friday, January 30
Fuller,Smith & Turner	Trading Update
BT Group	Q3 Results
Vedanta Resources	Q3 Production Results
James Halstead	Trading Statement
KCOM Group	Trading Statement
Monday, February 2
RM	Full Year Results
Tuesday, February 3
BG Group	Full Year Results
BP	Full Year Results
Ocado Group	Full Year Results
Aberdeen Asset Management	Q1 Trading Statement
Alumasc Group	Half Year Results
Low & Bonar	Full Year Results
St Modwen Property	Full Year Results
TalkTalk Telecom Group	Interim Management Statement
Wednesday, February 4
GlaxoSmithKline	Full Year Results
Hargreaves Lansdown	Half Year Results
International Consolidated Airlines Group	January Traffic Statistics
Sky	Half Year Results
Victrex	Interim Management Statement
Daily Mail and General Trust	Trading Statement
GW Pharmaceuticals	Q1 Results
Thursday, February 5
Fusionex International	Full Year Results
McBride	Interim Results
Compass Group	Interim Management Statement
Beazley	Full Year Results
AstraZeneca	Full Year Results
EasyJet	January Traffic Statistics
Dairy Crest Group	Interim Management Statement
Future	Interim Management Statement
Enterprise Inns	Interim Management Statement
Grainger	Interim Management Statement
Smith & Nephew	Full Year Results
Vodafone Group	Interim Management Statement
Avanti Communications Group	Half Year Results
Copyright 2015 Alliance News Limited. All Rights Reserved.

Related Shares

Astrazeneca (AZN)

12,416.00 (-12.00 / -0.10%%)

12,408.00 - 12,410.00

International Airlines (IAG)

168.05 (3.05 / 1.85%%)

167.95 - 168.05

BP (BP.)

466.85 (6.20 / 1.35%%)

467.25 - 467.40

Smith & Nephew (SN.)

987.80 (0.60 / 0.06%%)

990.40 - 990.80

Fuller Smith & Turner (FSTA)

692.00 (-14.00 / -1.98%%)

694.00 - 700.00

Ocado (OCDO)

353.60 (6.10 / 1.76%%)

354.00 - 354.50

Victrex (VCT)

1,166.00 (16.00 / 1.39%%)

1,168.00 - 1,172.00

Hargreaves Lansdown (HL.)

1,130.00 (56.50 / 5.26%%)

1,127.00 - 1,127.50

Mcbride (MCB)

127.50 (3.00 / 2.41%%)

127.00 - 128.50

Future (FUTR)

995.00 (2.00 / 0.20%%)

991.50 - 993.00

Beazley (BEZ)

681.00 (7.50 / 1.11%%)

682.50 - 683.50

Alumasc Group (ALU)

192.50 (0.00 / 0.00%%)

190.00 - 195.00

Vodafone (VOD)

70.64 (0.86 / 1.23%%)

70.44 - 70.48

Glaxosmithkline (GSK)

1,612.00 (12.00 / 0.75%%)

1,613.00 - 1,614.00

BT (BT.A)

141.10 (2.45 / 1.77%%)

141.05 - 141.15

Grainger plc (GRI)

239.00 (2.00 / 0.84%%)

237.50 - 238.50

Compass Group (CPG)

2,217.00 (21.00 / 0.96%%)

2,218.00 - 2,220.00

easyJet (EZJ)

452.10 (1.70 / 0.38%%)

452.60 - 452.90

Rm (RM.)

84.50 (-1.00 / -1.20%%)

79.50 - 84.50

Today 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

Today 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

Today 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Ba...